Even Walseng

854 total citations
19 papers, 716 citations indexed

About

Even Walseng is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Even Walseng has authored 19 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Even Walseng's work include Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (8 papers). Even Walseng is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (8 papers). Even Walseng collaborates with scholars based in United States, Norway and Japan. Even Walseng's co-authors include Paul A. Roche, Oddmund Bakke, Kazuyuki Furuta, Satoshi Ishido, Karis A. Weih, Gustav Gaudernack, Gunnar Kvalheim, Kyungjin Cho, Christoph Rader and Terrence R. Burke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Even Walseng

18 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Even Walseng United States	11	353	290	269	109	87	19	716
Dahlia M. Besmer United States	11	213 0.6×	317 1.1×	397 1.5×	80 0.7×	48 0.6×	14	679
Melissa Wassink Netherlands	13	435 1.2×	184 0.6×	453 1.7×	91 0.8×	42 0.5×	16	828
Joanna Brzostek Singapore	17	611 1.7×	356 1.2×	215 0.8×	53 0.5×	25 0.3×	33	907
Lora K. Picton United States	14	447 1.3×	442 1.5×	379 1.4×	77 0.7×	16 0.2×	23	945
Galit Denkberg Israel	15	745 2.1×	448 1.5×	259 1.0×	272 2.5×	14 0.2×	21	959
Becky Yang United States	11	495 1.4×	249 0.9×	538 2.0×	133 1.2×	52 0.6×	15	984
Ming-Ru Wu United States	12	359 1.0×	423 1.5×	349 1.3×	52 0.5×	31 0.4×	18	837
Anna Oszmiana United Kingdom	12	184 0.5×	132 0.5×	175 0.7×	26 0.2×	75 0.9×	12	586
Catarina Sacristán United States	7	450 1.3×	188 0.6×	152 0.6×	39 0.4×	46 0.5×	9	704
Jill M. Carton United States	12	277 0.8×	147 0.5×	482 1.8×	109 1.0×	97 1.1×	20	850

Countries citing papers authored by Even Walseng

Since Specialization

Citations

This map shows the geographic impact of Even Walseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even Walseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even Walseng more than expected).

Fields of papers citing papers by Even Walseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Even Walseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even Walseng. The network helps show where Even Walseng may publish in the future.

Co-authorship network of co-authors of Even Walseng

This figure shows the co-authorship network connecting the top 25 collaborators of Even Walseng. A scholar is included among the top collaborators of Even Walseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Even Walseng. Even Walseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Cole, Nelson B., et al.. (2025). CD83 suppresses endogenous March-I-dependent MHC class II ubiquitination, endocytosis, and degradation. Proceedings of the National Academy of Sciences. 122(21). e2504077122–e2504077122.

Walseng, Even, et al.. (2023). Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers. Frontiers in Immunology. 14. 1275304–1275304. 2 indexed citations

Koelzer, Viktor H., Petra Herzig, Inti Zlobec, et al.. (2021). Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform. Immuno-Oncology Technology. 10. 100034–100034. 2 indexed citations

Walseng, Even & Paul A. Roche. (2019). Monitoring Protein Endocytosis and Recycling Using FACS-Based Assays. Methods in molecular biology. 1988. 279–288. 1 indexed citations

Walseng, Even, Hakan Köksal, Ibrahim M. Sektioglu, et al.. (2017). A TCR-based Chimeric Antigen Receptor. Scientific Reports. 7(1). 10713–10713. 79 indexed citations

Li, Xiuling, Even Walseng, David Hymel, et al.. (2017). Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates. Nature Communications. 8(1). 1112–1112. 78 indexed citations

Walseng, Even, et al.. (2017). The role of transmembrane domains in the March-I-mediated downregulation of MHC-II and CD86.. The Journal of Immunology. 198(Supplement_1). 146.24–146.24. 1 indexed citations

Walseng, Even, Junpeng Qi, William Roush, et al.. (2016). Chemically Programmed Bispecific Antibodies in Diabody Format. Journal of Biological Chemistry. 291(37). 19661–19673. 33 indexed citations

Mensali, Nadia, Ying Fan, Vincent Yi Sheng Oei, et al.. (2016). Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA. OncoImmunology. 5(5). e1138199–e1138199. 6 indexed citations

10.

Almåsbak, Hilde, Even Walseng, Alexander Kristian, et al.. (2015). Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model. Gene Therapy. 22(5). 391–403. 94 indexed citations

11.

Walseng, Even, et al.. (2015). Soluble T-Cell Receptors Produced in Human Cells for Targeted Delivery. PLoS ONE. 10(4). e0119559–e0119559. 20 indexed citations

12.

Tadesse, Fitsum G., Nadia Mensali, Lars-Egil Fallang, et al.. (2015). Unpredicted phenotypes of two mutants of the TcR DMF5. Journal of Immunological Methods. 425. 37–44. 1 indexed citations

13.

Cho, Kyungjin, Even Walseng, Satoshi Ishido, & Paul A. Roche. (2015). Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells. Proceedings of the National Academy of Sciences. 112(33). 10449–10454. 60 indexed citations

14.

Furuta, Kazuyuki, Even Walseng, & Paul A. Roche. (2013). Internalizing MHC class II–peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation. Proceedings of the National Academy of Sciences. 110(50). 20188–20193. 35 indexed citations

15.

Skjeldal, Frode Miltzow, et al.. (2012). The fusion of early endosomes induces molecular motor-driven tubule formation and fission.. Journal of Cell Science. 125(Pt 8). 1910–9. 49 indexed citations

16.

Banik, Debarati, A. Nazmul H. Khan, Even Walseng, Brahm H. Segal, & Scott I. Abrams. (2012). Interferon Regulatory Factor-8 Is Important for Histone Deacetylase Inhibitor-Mediated Antitumor Activity. PLoS ONE. 7(9). e45422–e45422. 10 indexed citations

17.

Walseng, Even, Kazuyuki Furuta, Romina S. Goldszmid, et al.. (2010). Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus. Journal of Biological Chemistry. 285(53). 41749–41754. 45 indexed citations

18.

Walseng, Even, Kazuyuki Furuta, Berta Bosch, et al.. (2010). Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proceedings of the National Academy of Sciences. 107(47). 20465–20470. 91 indexed citations

19.

Walseng, Even, Oddmund Bakke, & Paul A. Roche. (2008). Major Histocompatibility Complex Class II-Peptide Complexes Internalize Using a Clathrin- and Dynamin-independent Endocytosis Pathway. Journal of Biological Chemistry. 283(21). 14717–14727. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact